Saturday, 31 October 2026European Markets

POSTNL And STEF Have A High Dividend Yield And Return On Equity In The Integrated Freight & Logistics Industry.

Loading stream...

(vianews) - postnl (pnl.as) is among this list of stock assets with the highest dividend rate and return on equity on the integrated freight & logistics industry.

financial asset price forward dividend yield return on equity
postnl (pnl.as) €1.27 4.83% 28.5%
stef (stf.pa) €136.40 4.05% 15.7%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. postnl (pnl.as)

4.83% forward dividend yield and 28.5% return on equity

postnl n.v. provides postal and logistics services to businesses and consumers in the netherlands, rest of europe, and internationally. the company operates through parcels and mail in the netherlands and postnl other segments. it collects, sorts, transports, and delivers letters and parcels; and offers data management, direct marketing, and fulfillment services, as well as cross-border mail and parcels solutions. the company was formerly known as tnt n.v. and changed its name to postnl n.v. in may 2011. postnl n.v. is based in the hague, the netherlands.

earnings per share

as for profitability, postnl has a trailing twelve months eps of €0.06.

pe ratio

postnl has a trailing twelve months price to earnings ratio of 21.23. meaning, the purchaser of the share is investing €21.23 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.5%.

more news about postnl.

2. stef (stf.pa)

4.05% forward dividend yield and 15.7% return on equity

stef sa provides temperature-controlled road transport and logistics services for agri-food industry, and out-of-home foodservices. it transports fresh, frozen, and thermosensitive products; and seafood products. the company also provides maritime passenger and freight transport services between marseille and corsica; and co-packing services. it operates in france, italy, spain, portugal, belgium, the netherlands, switzerland, and the united kingdom. the company was founded in 1920 and is headquartered in paris, france.

earnings per share

as for profitability, stef has a trailing twelve months eps of €14.06.

pe ratio

stef has a trailing twelve months price to earnings ratio of 9.7. meaning, the purchaser of the share is investing €9.7 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.7%.

volume

today's last reported volume for stef is 2472 which is 43.55% above its average volume of 1722.

more news about stef.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com